nach oben

Archives of Gynecology and Obstetrics

Erschienen in:

27.04.2016 | Gynecologic Oncology

Sexual function and quality of life in gynecological cancer pre- and post-short-term brachytherapy: a prospective study

verfasst von: Kamilla Zomkowski, Ariana Machado Toryi, Cinara Sacomori, Mirella Dias, Fabiana Flores Sperandio

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 4/2016

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To evaluate the sexual function and quality of life pre- and post-gynecological cancer treatment with high-dose rate brachytherapy in the short term.

Methods

This is a descriptive and prospective study involving 20 women diagnosed with gynecological cancer aged between 18 and 70 years, resident in Florianopolis and the surrounding region. We used the Quality of Life Questionnaire Core-30 (QLQ-C30) 3.0 to assess quality of life pre- and post-brachytherapy treatment and the Female Sexual Function Index (FSFI) to assess sexual function.

Results

Regarding quality of life, significant worsening was observed for the items loss of appetite (p = 0.002) and diarrhea (p = 0.045) from pre- to post-brachytherapy treatment, whereas constipation (p = 0.013) improved. For sexual function, the statistical difference was found exclusively in the domain of lubrication reduction (p = 0.046). Only nine women were sexually active before and after brachytherapy treatment.

Conclusions

There was a worsening of quality of life in comparing pre- and post-evaluations related to gastrointestinal symptoms over a period equivalent to 40 days. Regarding sexual function, lack of lubrication was identified in short-term post-gynecological cancer brachytherapy.

Lanciano RM, Won M, Coia LR, Hanks GE (1991) Pretreatment and treatment factors associated with improved outcome in squamous cell carcinoma of the uterine cervix: a final report of the 1973 and 1978 patterns of care studies. Int J Radiat Oncol Biol Phys 20(4):667–676CrossRefPubMed

Viswanathan AN, Beriwal S, De Los Santos JF, Demanes DJ, Gaffney D, Hansen J, Jones E, Kirisits C, Thomadsen B, Erickson B (2012) American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part II: high-dose-rate brachytherapy. Brachytherapy 11(1):47–52CrossRefPubMedPubMedCentral

Stewart AJ, Viswanathan AN (2006) Current controversies in high-dose-rate versus low-dose-rate brachytherapy for cervical cancer. Cancer 107(5):908–915. doi:10.1002/cncr.22054 CrossRefPubMed

Hannoun-Levi J-M, Chand-Fouche M-E, Gautier M, Dejean C, Marcy M, Fouche Y (2013) Interstitial preoperative high-dose-rate brachytherapy for early stage cervical cancer: dose-volume histogram parameters, pathologic response and early clinical outcome. Brachytherapy 12(2):148–155CrossRefPubMed

Abbott-Anderson K, Kwekkeboom KL (2012) A systematic review of sexual concerns reported by gynecological cancer survivors. Gynecol Oncol 124(3):477–489. doi:10.1016/j.ygyno.2011.11.030 CrossRefPubMed

Frumovitz M, Sun CC, Schover LR, Munsell MF, Jhingran A, Wharton JT, Eifel P, Bevers TB, Levenback CF, Gershenson DM, Bodurka DC (2005) Quality of life and sexual functioning in cervical cancer survivors. J Clin Oncol 23(30):7428–7436. doi:10.1200/JCO.2004.00.3996 CrossRefPubMed

Bjelic-Radisic V, Jensen PT, Vlasic KK, Waldenstrom AC, Singer S, Chie W, Nordin A, Greimel E (2012) Quality of life characteristics inpatients with cervical cancer. Eur J Cancer 48(16):3009–3018. doi:10.1016/j.ejca.2012.05.011 CrossRefPubMed

Viani GA, Manta GB, Stefano EJ, de Fendi LI (2009) Brachytherapy for cervix cancer: low-dose rate or high-dose rate brachytherapy - a meta-analysis of clinical trials. J Exp Clin Cancer Res 28:47. doi:10.1186/1756-9966-28-47 CrossRefPubMedPubMedCentral

Leroy T, Gabelle Flandin I, Habold D, Hannoun-Levi JM (2012) The impact of radiation therapy on sexual function. Cancer Radiother 16(5–6):377–385. doi:10.1016/j.canrad.2012.05.012 CrossRefPubMed

10.

Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC et al (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85(5):365–376CrossRefPubMed

11.

List of translations available by language—validated modules and C30 (2015) EORTC. http://groups.eortc.be/qol/eortc-qlq-c30

12.

Rosen R, Brown C, Heiman J, Leiblum S, Meston C, Shabsigh R, Ferguson D, D’Agostino R Jr (2000) The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther 26(2):191–208. doi:10.1080/009262300278597 CrossRefPubMed

13.

Pacagnella RdC, Martinez EZ, Vieira EM (2009) Construct validity of a Portuguese version of the Female Sexual Function Index. Cad Saude Publica 25(11):2333–2344CrossRef

14.

Wiegel M, Meston C, Rosen R (2005) The female sexual function index (FSFI): cross-validation and development of clinical cutoff scores. J Sex Marital Ther 31(1):1–20CrossRefPubMed

15.

Barillot I, Maingon P, Truc G, Horiot J (2000) Complications des traitements des cancers invasifs du col utérin sur utérus intact. Résultats et prévention. Cancer Radiother 4(2):147–158CrossRef

16.

Mahantshetty U, Shrivastava S, Kalyani N, Banerjee S, Engineer R, Chopra S (2014) Template-based high-dose-rate interstitial brachytherapy in gynecologic cancers: a single institutional experience. Brachytherapy 13(4):337–342. doi:10.1016/j.brachy.2013.09.009 CrossRefPubMed

17.

Yamashita H, Niibe Y, Toita T, Kazumoto T, Nishimura T, Kodaira T, Eto H, Kinoshita R, Tsujino K, Onishi H, Takemoto M, Hayakawa K (2013) High-dose-rate intra-cavitary brachytherapy combined with external beam radiation therapy for under 40-year-old patients with invasive uterine cervical carcinoma: clinical outcomes in 118 Patients in a Japanese multi-institutional study, JASTRO. Jpn J Clin Oncol. 43(5):547–552. doi:10.1093/jjco/hyt029 CrossRefPubMed

18.

Klee M, Thranov I, Machin Prof D (2000) The patients’ perspective on physical symptoms after radiotherapy for cervical cancer. Gynecol Oncol 76(1):14–23. doi:10.1006/gyno.1999.5642 CrossRefPubMed

19.

Greimel ER, Winter R, Kapp KS, Haas J (2009) Quality of life and sexual functioning after cervical cancer treatment: a long-term follow-up study. Psycho-Oncol 18(5):476–482CrossRef

20.

Barnas E, Skret-Magierlo J, Skret A, Bidzinski M (2012) The quality of life of women treated for cervical cancer. Eur J Oncol Nurs 16(1):59–63. doi:10.1016/j.ejon.2011.03.001 CrossRefPubMed

21.

Hsu WC, Chung NN, Chen YC, Ting LL, Wang PM, Hsieh PC, Chan SC (2009) Comparison of surgery or radiotherapy on complications and quality of life in patients with the stage IB and IIA uterine cervical cancer. Gynecol Oncol 115(1):41–45. doi:10.1016/j.ygyno.2009.06.028 CrossRefPubMed

22.

Vistad I, Cvancarova M, Fossa SD, Kristensen GB (2008) Postradiotherapy morbidity in long-term survivors after locally advanced cervical cancer: how well do physicians’ assessments agree with those of their patients? Int J Radiat Oncol Biol Phys 71(5):1335–1342. doi:10.1016/j.ijrobp.2007.12.030 CrossRefPubMed

23.

Vaz AF, Conde DM, Costa-Paiva L, Morais SS, Esteves SB, Pinto-Neto AM (2011) Quality of life and adverse events after radiotherapy in gynecologic cancer survivors: a cohort study. Arch Gynecol Obstet 284(6):1523–1531. doi:10.1007/s00404-011-1886-x CrossRefPubMed

24.

Kaidar-Person O, Abdah-Bortnyak R, Amit A, Nevelsky A, Berniger A, Bar-Deroma R, Ben-Yosef R, Kuten A (2014) Tolerance of the vaginal vault to high-dose rate brachytherapy and concomitant chemo-pelvic irradiation: Long-term perspective. Rep Pract Oncol Radiother. 19(1):56–61. doi:10.1016/j.rpor.2013.09.005 CrossRefPubMed

25.

Rodrigues AC, Teixeira R, Teixeira T, Conde S, Soares P, Torgal I (2012) Impact of pelvic radiotherapy on female sexuality. Arch Gynecol Obstet 285(2):505–514. doi:10.1007/s00404-011-1988-5 CrossRefPubMed

26.

Bradley S, Rose S, Lutgendorf S, Costanzo E, Anderson B (2006) Quality of life and mental health in cervical and endometrial cancer survivors. Gynecol Oncol 100(3):479–486. doi:10.1016/j.ygyno.2005.08.023 CrossRefPubMed

27.

Smits A, Lopes A, Das N, Bekkers R, Galaal K (2014) The impact of BMI on quality of life in obese endometrial cancer survivors: does size matter? Gynecol Oncol 132(1):137–141. doi:10.1016/j.ygyno.2013.11.018 CrossRefPubMed

28.

Ljuca DMG (2009) Quality of life in patients with cervical cancer FIGO IIb stage after concomitant chemoradiotherapy. Radiol Oncol 43(4):6. doi:10.2478/v10019-009-0025-9 CrossRef

29.

Herzog TJ, Wright JD (2007) The impact of cervical cancer on quality of life-the components and means for management. Gynecol Oncol 107(3):572–577CrossRefPubMed

30.

Friedman LC, Abdallah R, Schluchter M, Panneerselvam A, Kunos CA (2011) Adherence to vaginal dilation following high dose rate brachytherapy for endometrial cancer. Int J Radiat Oncol Biol Phys 80(3):751–757CrossRefPubMed

31.

Grion RC, Baccaro LF, Vaz AF, Costa-Paiva L, Conde DM, Pinto-Neto AM (2015) Sexual function and quality of life in women with cervical cancer before radiotherapy: a pilot study. Arch Gynecol Obstet 293(4):879–886. doi:10.1007/s00404-015-3874-z CrossRefPubMed

32.

Quinn M (2007) Sexual function after treatment of gynaecological cancer. Sexologies 16(4):286–291CrossRef

33.

Duncan LE, Lewis C, Jenkins P, Pearson TA (2000) Does hypertension and its pharmacotherapy affect the quality of sexual function in women? Am J Hypertens 13(6 Pt 1):640–647CrossRefPubMed

34.

Llisterri Caro J, Sánchez Sánchez F, Brotons Muntó F (2005) Disfunción sexual en la hipertensión arterial. Hipertensión 22(2):59–72CrossRef

35.

Iavazzo C, Johnson K, Savage H, Gallagher S, Datta M, Winter-Roach BA (2014) Sexuality issues in gynaecological oncology patients: post treatment symptoms and therapeutic options. Arch Gynecol Obstet 291(3):653–656. doi:10.1007/s00404-014-3491-2 CrossRefPubMed

36.

Huffman LB, Hartenbach EM, Carter J, Rash JK, Kushner DM (2016) Maintaining sexual health throughout gynecologic cancer survivorship: a comprehensive review and clinical guide. Gynecol Oncol 140(2):359–368CrossRefPubMed

37.

Kim M-K, Sim JA, Yun YH, Bae D-S, Nam JH, Park CT, Cho C-H, Lee J-M, Park SY (2016) Health-related quality of life and sociodemographic characteristics as prognostic indicators of long-term survival in disease-free cervical cancer survivors. Int J Gynecol Cancer 00:00

Titel: Sexual function and quality of life in gynecological cancer pre- and post-short-term brachytherapy: a prospective study
verfasst von: Kamilla Zomkowski
Ariana Machado Toryi
Cinara Sacomori
Mirella Dias
Fabiana Flores Sperandio
Publikationsdatum: 27.04.2016
Verlag: Springer Berlin Heidelberg
Erschienen in: Archives of Gynecology and Obstetrics / Ausgabe 4/2016
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI: https://doi.org/10.1007/s00404-016-4099-5

Neu im Fachgebiet Gynäkologie und Geburtshilfe

Antikörper-Wirkstoff-Konjugat hält solide Tumoren in Schach

16.05.2024 Zielgerichtete Therapie Nachrichten

Trastuzumab deruxtecan scheint auch jenseits von Lungenkrebs gut gegen solide Tumoren mit HER2-Mutationen zu wirken. Dafür sprechen die Daten einer offenen Pan-Tumor-Studie.

Mammakarzinom: Senken Statine das krebsbedingte Sterberisiko?

15.05.2024 Mammakarzinom Nachrichten

Frauen mit lokalem oder metastasiertem Brustkrebs, die Statine einnehmen, haben eine niedrigere krebsspezifische Mortalität als Patientinnen, die dies nicht tun, legen neue Daten aus den USA nahe.

S3-Leitlinie zur unkomplizierten Zystitis: Auf Antibiotika verzichten?

15.05.2024 Harnwegsinfektionen Nachrichten

Welche Antibiotika darf man bei unkomplizierter Zystitis verwenden und wovon sollte man die Finger lassen? Welche pflanzlichen Präparate können helfen? Was taugt der zugelassene Impfstoff? Antworten vom Koordinator der frisch überarbeiteten S3-Leitlinie, Prof. Florian Wagenlehner.

Gestationsdiabetes: In der zweiten Schwangerschaft folgenreicher als in der ersten

13.05.2024 Gestationsdiabetes Nachrichten

Das Risiko, nach einem Gestationsdiabetes einen Typ-2-Diabetes zu entwickeln, hängt nicht nur von der Zahl, sondern auch von der Reihenfolge der betroffenen Schwangerschaften ab.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Sexual function and quality of life in gynecological cancer pre- and post-short-term brachytherapy: a prospective study